| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 253,812 | 257,725 | 232,074 | 245,037 | | Cost of Revenue | 215,610 | 219,644 | 198,427 | 216,319 | | | Gross Profit | 38,202 | 38,081 | 33,647 | 28,718 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,170 | 31,773 | 31,313 | 36,104 | | Non Recurring | 8,418 | (1,508) | 1,431 | 11,099 | | Others | 1,567 | 2,763 |
-
| 1,627 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,023) | 5,053 | 903 | (20,112) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (649) | 796 | (1,077) | 6,183 | | Earnings Before Interest And Taxes | (13,008) | 5,849 | (174) | (13,929) | | Interest Expense | (6,341) | 3,470 | 2,871 | 5,145 | | Income Before Tax | (6,667) | 2,379 | (3,045) | (19,074) | | Income Tax Expense | 269 | 833 | (1,066) | (1,375) | | Minority Interest |
-
|
-
|
-
| 654 | | | | Net Income From Continuing Ops | (9,684) | 1,546 | (1,979) | (17,045) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,116) | 1,546 | (1,979) | (17,045) | | Preferred Stock And Other Adjustments | (556) | 234 | 322 |
-
| | | Net Income Applicable To Common Shares | ($4,672) | $1,780 | ($1,657) | ($17,045) |
|
0.11% Nasdaq 0.00%
Income Statement
